ImmunoCellular Therapeutics Ltd (IMUC.A)

IMUC.A on American Stock Exchange

0.93USD
4:02pm EDT
Price Change (% chg)

$0.03 (+3.07%)
Prev Close
$0.90
Open
$0.91
Day's High
$0.95
Day's Low
$0.89
Volume
44,443
Avg. Vol
65,345
52-wk High
$4.00
52-wk Low
$0.65

IMUC.A

Chart for IMUC.A

About

ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient’s own immune system is stimulated to target tumor... (more)

Overall

Beta: 1.42
Market Cap (Mil.): $52.26
Shares Outstanding (Mil.): 57.92
Dividend: --
Yield (%): --

Financials

  IMUC.A Industry Sector
P/E (TTM): -- 99.85 35.92
EPS (TTM): -0.12 -- --
ROI: -28.59 -0.25 18.26
ROE: -33.34 -1.05 19.14
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: GlobalData
$125.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks